+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Food Allergy Diagnostics & Therapeutics Market - Global Forecast 2026-2032- Product Image
Food Allergy Diagnostics & Therapeutics Market - Global Forecast 2026-2032- Product Image
Sale

Food Allergy Diagnostics & Therapeutics Market - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5336334
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Food Allergy Diagnostics & Therapeutics Market is projected to reach USD 7.93 Billion in 2026. It is expected to continue growing at a CAGR of 10.72%, reaching USD 14.57 Billion by 2032.

Food allergy diagnostics and therapeutics are moving from episodic symptom management toward precision allergy care built on earlier diagnosis, molecular risk stratification, and targeted treatment. The clinical burden is significant: U.S. public health sources report food allergy in approximately 5.8% of children and 6.2% of adults, while global clinical literature consistently identifies rising prevalence, substantial emergency-care utilization, and quality-of-life impact across pediatric and adult populations.

Executive decision-making in this market is shaped by three evidence-based realities. Oral food challenge remains the diagnostic reference standard, but skin-prick testing, serum-specific IgE testing, component-resolved diagnostics, and emerging basophil activation testing are improving the ability to distinguish sensitization from clinically meaningful allergy. On the therapeutic side, avoidance and epinephrine remain foundational, while FDA-approved peanut oral immunotherapy and the 2024 FDA approval of omalizumab for IgE-mediated food allergy have expanded the treatment framework beyond single-allergen desensitization.

Transformative Shifts in the Food Allergy Landscape

The landscape is being reshaped by the convergence of molecular diagnostics, biologic therapy, patient-centered emergency treatment, and stricter allergen-labeling policy. In the United States, sesame became the ninth major food allergen under the FASTER Act in 2023, reinforcing how regulation is influencing testing panels, food manufacturing controls, and patient education. In Europe, mandatory disclosure of 14 regulated allergens continues to shape foodservice, packaged food compliance, and clinical counseling.

Clinically, the market is shifting from broad avoidance advice to quantified risk assessment. Component-resolved diagnostics are helping clinicians evaluate peanut, tree nut, milk, egg, wheat, and shellfish sensitization patterns, while digital symptom tracking and connected care models are improving follow-up. Therapeutics are also diversifying as oral immunotherapy, biologics, epicutaneous approaches, sublingual approaches, and improved epinephrine delivery formats create new opportunities for integrated diagnostic-treatment pathways.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a practical accelerator across food allergy diagnostics, clinical operations, and therapeutic development. In diagnostics, machine learning can support pattern recognition across serum-specific IgE, component testing, patient history, comorbid asthma, age, atopic dermatitis, and prior reaction severity, helping clinicians prioritize oral food challenges and reduce unnecessary dietary restriction when appropriately validated.

AI also improves trial design and real-world evidence generation by identifying eligible cohorts, modeling responder profiles, and analyzing longitudinal adherence data for oral immunotherapy and biologic use. For industry leaders, the most defensible AI strategies will be those built on transparent algorithms, diverse datasets, clinician oversight, explainable outputs, and compliance with medical device, data privacy, and health equity requirements.

Key Regional Insights Across Global Food Allergy Markets

Asia-Pacific is emerging as a high-priority region as urbanization, dietary diversification, pediatric allergy awareness, and expanding private diagnostics increase demand for IgE testing and specialist allergy services. Japan, China, South Korea, India, and Australia are particularly important because they combine large pediatric populations or mature healthcare systems with rising investment in immunology, digital health, and laboratory infrastructure. Australia also has extensive clinical and public health attention on food allergy due to well-documented pediatric prevalence and national allergy management initiatives.

North America remains the most advanced commercial environment due to high diagnosis rates, established allergist networks, FDA-cleared diagnostic platforms, food-labeling enforcement, school and emergency anaphylaxis protocols, and rapid uptake of approved therapies. Europe is characterized by strong clinical guidelines, the European Union’s mandatory labeling of 14 major allergens, established immunology research networks, and broad adoption of evidence-based allergy management through national health systems. Latin America, the Middle East, and Africa are earlier in market maturity, with adoption tied to urban hospital networks, private laboratories, medical tourism hubs, pediatric care expansion, clinician education, and gradual improvements in emergency anaphylaxis preparedness.

Key Group Insights for Strategic Market Expansion

ASEAN markets are gaining relevance as Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines expand pediatric care, private diagnostics, and hospital-based allergy services. Demand is strongest where middle-class growth supports specialist consultations and where foodservice globalization increases the need for reliable allergen risk management, packaged food labeling awareness, and school-based emergency response planning.

The GCC is investing in advanced healthcare infrastructure, specialty clinics, and imported diagnostic technologies, creating favorable conditions for premium allergy testing, biologic therapy adoption, and tertiary-care allergy programs. The European Union provides one of the world’s most structured allergy environments through harmonized food-labeling rules, pharmacovigilance systems, and guideline-driven care. BRICS economies combine large patient pools with uneven access, making scalable diagnostics, clinician training, and affordable emergency treatment central to growth. G7 countries lead in regulatory sophistication, reimbursement depth, clinical research, and patient advocacy, while NATO-aligned markets benefit indirectly from resilient medical supply chains, emergency preparedness frameworks, and coordinated health security planning.

Key Country Insights in Priority Food Allergy Markets

The United States leads global commercialization through high awareness, FDA oversight, sesame-labeling enforcement, approved peanut oral immunotherapy, and the 2024 approval of omalizumab for one or more IgE-mediated food allergies. Canada has strong public health guidance and specialist care access in urban centers, while Mexico and Brazil represent expanding Latin American opportunities as private diagnostics, pediatric allergy services, and urban hospital capabilities grow.

In Europe, the United Kingdom, Germany, France, Italy, and Spain benefit from robust guideline adoption, established allergology networks, emergency anaphylaxis guidance, and mandatory allergen disclosure, while Russia shows demand in major urban centers despite access variability. China and India offer scale, increasing hospital investment, expanding laboratory capacity, and rising allergy awareness, though access remains uneven outside major cities. Japan, Australia, and South Korea are mature Asia-Pacific markets with strong clinical practice standards, sophisticated diagnostics, established pediatric care pathways, and growing interest in precision immunology.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize integrated care models that connect validated diagnostics, risk stratification, patient education, epinephrine access, and therapy monitoring. Organizations that position testing as a gateway to evidence-based treatment decisions will be better placed than those offering isolated assays or single-point interventions.

Executives should invest in real-world evidence, health-economic studies, and workflow integration for allergists, pediatricians, emergency departments, dietitians, and primary care. Commercial teams should tailor strategies by market maturity: advanced economies require differentiation through precision diagnostics, patient support, and biologic pathway support, while emerging markets need affordable testing, clinician training, cold-chain reliability, supply continuity, and patient education on anaphylaxis recognition.

Research Methodology and Evidence Framework

This executive summary is built from an evidence-led assessment of food allergy diagnostics, therapeutics, regulatory developments, clinical guidelines, public health datasets, and technology adoption patterns. The methodology emphasizes verified sources such as national public health agencies, regulatory authorities, peer-reviewed allergy and immunology literature, clinical trial records, pharmacovigilance updates, and recognized professional guidance.

The analysis triangulates disease burden, diagnostic standards, therapeutic approvals, regional healthcare capacity, allergen-labeling policy, emergency treatment readiness, and commercial adoption conditions. Qualitative insights were structured around clinical utility, reimbursement feasibility, regulatory risk, adoption barriers, health equity, and scalability across hospital, laboratory, specialty clinic, primary care, school, and home-care settings.

Conclusion: Precision Allergy Care Is Defining the Next Phase

Food allergy diagnostics and therapeutics are entering a more sophisticated phase defined by precision testing, approved immunomodulatory therapy, improved emergency treatment options, and data-enabled care pathways. The strongest opportunities sit at the intersection of accurate diagnosis, measurable clinical outcomes, regulatory compliance, and patient-centered treatment access.

Organizations that combine scientific credibility with scalable delivery will be best positioned to lead. Success will depend on validating AI tools, demonstrating cost-effectiveness, supporting clinician adoption, improving patient adherence, and aligning product strategy with regional regulatory, reimbursement, and infrastructure realities.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Food Allergy Diagnostics & Therapeutics Market, by Product Type
7.1. Introduction
7.2. Diagnostic Tests
7.2.1. At-Home Allergy Tests
7.2.2. Component Resolved Diagnostics
7.2.3. Skin Prick Tests
7.2.4. Specific IgE Tests
7.3. Therapeutic Products
7.3.1. Antihistamines
7.3.2. Emergency Treatments
7.3.3. Immunotherapy
7.3.3.1. Epicutaneous Immunotherapy
7.3.3.2. Oral Immunotherapy
7.3.3.3. Subcutaneous Immunotherapy
7.3.4. Monoclonal Antibodies
8. Food Allergy Diagnostics & Therapeutics Market, by Allergen Type
8.1. Introduction
8.2. Egg Allergy
8.3. Fish Allergy
8.4. Milk Allergy
8.5. Peanut Allergy
8.6. Sesame Allergy
8.7. Shellfish Allergy
8.8. Soy Allergy
8.9. Tree Nut Allergy
8.10. Wheat Allergy
9. Food Allergy Diagnostics & Therapeutics Market, by Age Group
9.1. Introduction
9.2. Pediatric
9.3. Adults
9.4. Geriatric
10. Food Allergy Diagnostics & Therapeutics Market, by End User
10.1. Introduction
10.2. Hospital Laboratories
10.3. Point-Of-Care Settings
10.4. Reference Laboratories
10.5. Research Institutes
11. Food Allergy Diagnostics & Therapeutics Market, by Distribution Channel
11.1. Introduction
11.2. Clinics & Diagnostic Centers
11.3. Hospitals
11.4. Online
11.5. Pharmacies
12. Food Allergy Diagnostics & Therapeutics Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Food Allergy Diagnostics & Therapeutics Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Food Allergy Diagnostics & Therapeutics Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. ALK-Abelló A/S
16.2. Allergy Therapeutics plc
16.3. bioMérieux SA
16.4. DBV Technologies S.A.
16.5. Eurofins Scientific SE
16.6. HAL Allergy Group
16.7. HOB Biotech Group Corp. Ltd.
16.8. HYCOR Biomedical
16.9. Immunomic Therapeutics Inc.
16.10. Lincoln Diagnostics Inc.
16.11. Medeca Pharma AB
16.12. NEOGEN Corporation
16.13. Nestlé Health Science S.A.
16.14. Omega Diagnostics Group PLC
16.15. Pfizer Inc.
16.16. Prota Therapeutics Pty Ltd
16.17. Quest Diagnostics Incorporated
16.18. R-Biopharm AG
16.19. Sanofi S.A.
16.20. Siemens Healthineers AG
16.21. Stallergenes Greer International S.A.
16.22. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
FIGURE 11. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 15. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL DIAGNOSTIC TESTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL DIAGNOSTIC TESTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL DIAGNOSTIC TESTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL AT-HOME ALLERGY TESTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL AT-HOME ALLERGY TESTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL AT-HOME ALLERGY TESTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL COMPONENT RESOLVED DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL COMPONENT RESOLVED DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL COMPONENT RESOLVED DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL SKIN PRICK TESTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL SKIN PRICK TESTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL SKIN PRICK TESTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL SPECIFIC IGE TESTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL SPECIFIC IGE TESTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL SPECIFIC IGE TESTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL THERAPEUTIC PRODUCTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL THERAPEUTIC PRODUCTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL THERAPEUTIC PRODUCTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL ANTIHISTAMINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL ANTIHISTAMINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL ANTIHISTAMINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL EMERGENCY TREATMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL EMERGENCY TREATMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL EMERGENCY TREATMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL IMMUNOTHERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL IMMUNOTHERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL EPICUTANEOUS IMMUNOTHERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL EPICUTANEOUS IMMUNOTHERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL EPICUTANEOUS IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL ORAL IMMUNOTHERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL ORAL IMMUNOTHERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL ORAL IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL SUBCUTANEOUS IMMUNOTHERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL SUBCUTANEOUS IMMUNOTHERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL SUBCUTANEOUS IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL MONOCLONAL ANTIBODIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL MONOCLONAL ANTIBODIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL MONOCLONAL ANTIBODIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL EGG ALLERGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL EGG ALLERGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL EGG ALLERGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL FISH ALLERGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL FISH ALLERGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL FISH ALLERGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL MILK ALLERGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL MILK ALLERGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL MILK ALLERGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL PEANUT ALLERGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL PEANUT ALLERGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL PEANUT ALLERGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL SESAME ALLERGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL SESAME ALLERGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL SESAME ALLERGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL SHELLFISH ALLERGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL SHELLFISH ALLERGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL SHELLFISH ALLERGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL SOY ALLERGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL SOY ALLERGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL SOY ALLERGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL TREE NUT ALLERGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL TREE NUT ALLERGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL TREE NUT ALLERGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL WHEAT ALLERGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL WHEAT ALLERGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL WHEAT ALLERGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL ADULTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL ADULTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL ADULTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL HOSPITAL LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL HOSPITAL LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL HOSPITAL LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL POINT-OF-CARE SETTINGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL POINT-OF-CARE SETTINGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL POINT-OF-CARE SETTINGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL CLINICS & DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL CLINICS & DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL CLINICS & DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL ONLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 110. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2017-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2017-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 117. NORTH AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. NORTH AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 119. NORTH AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2017-2032 (USD MILLION)
TABLE 120. NORTH AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2017-2032 (USD MILLION)
TABLE 121. NORTH AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 122. NORTH AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 123. NORTH AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 124. NORTH AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 125. NORTH AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 126. LATIN AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 127. LATIN AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 128. LATIN AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2017-2032 (USD MILLION)
TABLE 129. LATIN AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2017-2032 (USD MILLION)
TABLE 130. LATIN AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 131. LATIN AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 132. LATIN AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 133. LATIN AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 134. LATIN AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 135. EUROPE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 136. EUROPE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 137. EUROPE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2017-2032 (USD MILLION)
TABLE 138. EUROPE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2017-2032 (USD MILLION)
TABLE 139. EUROPE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 140. EUROPE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 141. EUROPE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 142. EUROPE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 143. EUROPE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 144. MIDDLE EAST FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 145. MIDDLE EAST FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 146. MIDDLE EAST FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2017-2032 (USD MILLION)
TABLE 147. MIDDLE EAST FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2017-2032 (USD MILLION)
TABLE 148. MIDDLE EAST FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 149. MIDDLE EAST FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 150. MIDDLE EAST FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 151. MIDDLE EAST FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 152. MIDDLE EAST FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 153. AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 154. AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 155. AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2017-2032 (USD MILLION)
TABLE 156. AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2017-2032 (USD MILLION)
TABLE 157. AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 158. AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 159. AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 160. AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 161. AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 162. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 163. ASEAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 164. ASEAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 165. ASEAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2017-2032 (USD MILLION)
TABLE 166. ASEAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2017-2032 (USD MILLION)
TABLE 167. ASEAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 168. ASEAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 169. ASEAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 170. ASEAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 171. ASEAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 172. GCC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 173. GCC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 174. GCC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2017-2032 (USD MILLION)
TABLE 175. GCC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2017-2032 (USD MILLION)
TABLE 176. GCC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 177. GCC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 178. GCC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 179. GCC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 180. GCC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2017-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2017-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 190. BRICS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 191. BRICS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 192. BRICS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2017-2032 (USD MILLION)
TABLE 193. BRICS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2017-2032 (USD MILLION)
TABLE 194. BRICS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 195. BRICS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 196. BRICS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 197. BRICS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 198. BRICS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 199. G7 FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 200. G7 FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 201. G7 FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2017-2032 (USD MILLION)
TABLE 202. G7 FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2017-2032 (USD MILLION)
TABLE 203. G7 FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 204. G7 FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 205. G7 FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 206. G7 FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 207. G7 FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 208. NATO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 209. NATO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 210. NATO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2017-2032 (USD MILLION)
TABLE 211. NATO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2017-2032 (USD MILLION)
TABLE 212. NATO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 213. NATO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 214. NATO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 215. NATO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 216. NATO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 217. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 218. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 219. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 220. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2017-2032 (USD MILLION)
TABLE 221. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2017-2032 (USD MILLION)
TABLE 222. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 223. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 224. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 225. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 226. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 227. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 228. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 229. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2017-2032 (USD MILLION)
TABLE 230. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2017-2032 (USD MILLION)
TABLE 231. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 232. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 233. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 234. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 235. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 236. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 237. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 238. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2017-2032 (USD MILLION)
TABLE 239. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2017-2032 (USD MILLION)
TABLE 240. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 241. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 242. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 243. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 244. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 245. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 246. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 247. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2017-2032 (USD MILLION)
TABLE 248. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2017-2032 (USD MILLION)
TABLE 249. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 250. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 251. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 252. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 253. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 254. UNITED KINGDOM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 255. UNITED KINGDOM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 256. UNITED KINGDOM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2017-2032 (USD MILLION)
TABLE 257. UNITED KINGDOM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2017-2032 (USD MILLION)
TABLE 258. UNITED KINGDOM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 259. UNITED KINGDOM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 260. UNITED KINGDOM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 261. UNITED KINGDOM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 262. UNITED KINGDOM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 263. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 264. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 265. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2017-2032 (USD MILLION)
TABLE 266. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2017-2032 (USD MILLION)
TABLE 267. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 268. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 269. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 270. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 271. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 272. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 273. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 274. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2017-2032 (USD MILLION)
TABLE 275. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2017-2032 (USD MILLION)
TABLE 276. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 277. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 278. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 279. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 280. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 281. RUSSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 282. RUSSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 283. RUSSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2017-2032 (USD MILLION)
TABLE 284. RUSSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2017-2032 (USD MILLION)
TABLE 285. RUSSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 286. RUSSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 287. RUSSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 288. RUSSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 289. RUSSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 290. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 291. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 292. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2017-2032 (USD MILLION)
TABLE 293. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2017-2032 (USD MILLION)
TABLE 294. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 295. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 296. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 297. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 298. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 299. SPAIN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 300. SPAIN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 301. SPAIN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2017-2032 (USD MILLION)
TABLE 302. SPAIN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2017-2032 (USD MILLION)
TABLE 303. SPAIN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 304. SPAIN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 305. SPAIN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 306. SPAIN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 307. SPAIN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 308. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 309. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 310. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2017-2032 (USD MILLION)
TABLE 311. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2017-2032 (USD MILLION)
TABLE 312. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 313. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 314. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 315. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 316. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2

Companies Mentioned

  • ALK-Abelló A/S
  • Allergy Therapeutics plc
  • bioMérieux SA
  • DBV Technologies S.A.
  • Eurofins Scientific SE
  • HAL Allergy Group
  • HOB Biotech Group Corp. Ltd.
  • HYCOR Biomedical
  • Immunomic Therapeutics Inc.
  • Lincoln Diagnostics Inc.
  • Medeca Pharma AB
  • NEOGEN Corporation
  • Nestlé Health Science S.A.
  • Omega Diagnostics Group PLC
  • Pfizer Inc.
  • Prota Therapeutics Pty Ltd
  • Quest Diagnostics Incorporated
  • R‑Biopharm AG
  • Sanofi S.A.
  • Siemens Healthineers AG
  • Stallergenes Greer International S.A.
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages196
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 7.93 Billion
Forecasted Market Value ( USD ) by 2032 $ 14.57 Billion
Compound Annual Growth Rate10.7%
Regions CoveredGlobal
No. of Companies Mentioned22

Related Topics

Related Reports

Allergy Diagnostics Market - Global Forecast 2026-2032 - Product Image

Allergy Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Allergy Diagnostics and Therapeutics Market Size, Share & Trends Analysis Report by Type (Diagnostics, Therapeutics), Allergen Type (Food, Inhaled, Drug), Test Type (in Vivo Tests, in Vitro Tests), and Region with Growth Forecasts, 2026-2033 - Product Image

Allergy Diagnostics and Therapeutics Market Size, Share & Trends Analysis Report by Type (Diagnostics, Therapeutics), Allergen Type (Food, Inhaled, Drug), Test Type (in Vivo Tests, in Vitro Tests), and Region with Growth Forecasts, 2026-2033

  • Report
  • 150 Pages
  • Global
From
Allergy Diagnostics and Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Allergy Diagnostics and Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 186 Pages
  • Global
From
Allergy Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2034 - Product Image

Allergy Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2034

  • Report
  • 150 Pages
  • Global
From
Food Allergy Diagnostics & Therapeutics Market Size, Share & Growth Analysis Report - Industry Trends, Competitive Landscape, Segment Insights (by Product Type, Application, End-User), and Forecast 2024-2034 - Product Image

Food Allergy Diagnostics & Therapeutics Market Size, Share & Growth Analysis Report - Industry Trends, Competitive Landscape, Segment Insights (by Product Type, Application, End-User), and Forecast 2024-2034

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.